A Prospective, open labeled, clinical study to evaluate the efficacy and safety of DENPAP of liquid syrup in the treatment of Dengue fever

GOAN Pharma P Ltd0 个研究点目标入组 15 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Males and females of age group 18-60 years
•2.Subjects with low platelet count(>=70,000) and IgG or IgM or both antibodies positive cases only
•3.Subjects who are willing to give written informed consent along with audio, video recording
•4.Patient is willing and able to comply with all trial requirements

•1.Patients with adequate platelet count and IgG and IgM antibodies negative
•2.Subjects had bleeding manifestations or mixed infections (tested positive for malaria, leptospirosis along with dengue) or a recent ( <120 days) transfusion of plate-lets & whole blood
•3.Have a history of Angina, stroke, thyroid diseases
•4.Present history of mental diseases
•5.Previous participation in a clinical trial within 6 months.
•6.Pregnant or lactating woman

发起方

GOAN Pharma P Ltd